Google
TNDM Stock Analysis — TANDEM DIABETES CARE INC (Healthcare >> Medical Devices)
TNDM FAQ
What is TNDM's P/E ratio?
TANDEM DIABETES CARE INC (TNDM) currently trades at a P/E ratio of -2,211.78.
What is TNDM's ROE?
TANDEM DIABETES CARE INC reports a Return on Equity (ROE) of -71.41%.
What is TNDM's dividend yield?
TANDEM DIABETES CARE INC offers a dividend yield of 0.00%.
What is TNDM's Quality Score?
Our AI rates TNDM's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TNDM?
Our AI Timing Score for TNDM is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TNDM belong to?
TANDEM DIABETES CARE INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
TNDM AI Analysis Summary
Our AI summary for TNDM: TANDEM DIABETES CARE INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of -2,211.78, ROE of -71.41%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 19.50
Price
0.49
(2.58%)
Day Change
|
|
|---|
TNDM, the overall quality is not good ( Quality = 46) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 19.50 |
| PBV / Sector |
9.84 / -101.57
|
| Earning Per Share | -1.42 |
| PE / Sector |
N/A / 31.23
|
| PEG or PE/Growth / Sector |
-36.35 / 0.40
|
| Average 1M Daily Value |
27.60 M
GREAT
|
| Average 1W Daily Value |
33.62 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:35 |
| Symbol | TNDM |
| Name | TANDEM DIABETES CARE INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 68.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,302.74 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 12400 High Bluff Drive, San Diego, CA, United States, 92130
Phone: 858 366 6900
Website: https://www.tandemdiabetes.com
Employees: 2,500
Sector: Healthcare >> Medical Devices
Description: Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
